Keiichi Kato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Keiichi Kato has a total of 205 co-authors. Here are the top co-authors by number of shared publications:
- Kenji Ezoe
Kato Ladies Clinic, 7-20-3 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
31 shared publications Tamotsu Kobayashi
Kato Ladies Clinic, Tokyo, Japan
23 shared publicationsTadashi Okimura
Kato Ladies Clinic, Shinjuku, Tokyo, Japan
21 shared publicationsSatoshi Ueno
Kato Ladies Clinic, Tokyo, Japan
18 shared publicationsTetsuya Miki
17 shared publicationsAkiko Yabuuchi
Kato Ladies Clinic, Tokyo, Japan
16 shared publications
Latest Publications
- 20 November 2025
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 52 (4) , 105417
Post-warming culture and single vitrified-warmed blastocyst transfer with hyaluronic acid and prolactin: a randomized controlled trial
- 20 November 2025
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 52 (4) , 105417
Post-warming culture and single vitrified-warmed blastocyst transfer with hyaluronic acid and prolactin: a randomized controlled trial
- 24 October 2025
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 53 (2) , 105360
Artificial intelligence-driven oocyte scores are associated with early morphokinetics and embryo outcomes after intracytoplasmic sperm injection
- 24 October 2025
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 53 (2) , 105360
Artificial intelligence-driven oocyte scores are associated with early morphokinetics and embryo outcomes after intracytoplasmic sperm injection
- 7 October 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (10) , 3479-3491
Validation of non-invasive preimplantation genetic testing for aneuploidies (niPGT-A) in a Japanese population: experience from seven clinics
Purpose The aim of this study was to determine the feasibility of implementing non-invasive PGT-A (niPGT-A) in clinical practice. Informativity and concordance rates between three sample types (embryonic cell-free DNA [cfDNA] present in spent blastocyst medium [SBM], trophectoderm [TE] biopsy, and whole blastocyst [WB]) from the same embryo were evaluated. Methods This was a prospective, multicenter study conducted between February 2022 and November 2022 at seven Japanese IVF centres. 212 blastocysts were donated for research. The cfDNA released into the SBM was analysed, and the results were compared against the corresponding TE biopsy and WB sample. Results Overall informativity rates for SBM, TE, and WB were 81.6% (173/212), 98.6% (209/212), and 98.6% (209/212), respectively. There was no difference between TE and WB; however, SBM was significantly different to both (p < 0.001). The informativity rate in SBM samples significantly varied among the seven centres, ranging between 72.7 and 97.1% (p = 0.041). Ploidy concordance (SBM-TE) also varied across the centres, ranging between 68.2 and 90.9%; however, this did not reach statistical significance (p = 0.63). Ploidy concordance rates in SBM-TE, SBM-WB, and TE-WB were 77.4% (130/168), 77.4% (130/168), and 90.5% (152/168), respectively. There was no statistical difference for SBM-TE and SBM-WB, but both were statistically different to TE-WB (p = 0.0054). Conclusion We have shown results that are consistent with the existing literature, indicating the feasibility of applying the niPGT-A protocol described here, and thus using the SBM result to establish a priority for embryo transfer. Trial registration information The study was approved by Tokushima University Hospital Life Science and Medical Research Ethics Review Committee (Permission number: 4057).
- 7 October 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (10) , 3479-3491
Validation of non-invasive preimplantation genetic testing for aneuploidies (niPGT-A) in a Japanese population: experience from seven clinics
Purpose The aim of this study was to determine the feasibility of implementing non-invasive PGT-A (niPGT-A) in clinical practice. Informativity and concordance rates between three sample types (embryonic cell-free DNA [cfDNA] present in spent blastocyst medium [SBM], trophectoderm [TE] biopsy, and whole blastocyst [WB]) from the same embryo were evaluated. Methods This was a prospective, multicenter study conducted between February 2022 and November 2022 at seven Japanese IVF centres. 212 blastocysts were donated for research. The cfDNA released into the SBM was analysed, and the results were compared against the corresponding TE biopsy and WB sample. Results Overall informativity rates for SBM, TE, and WB were 81.6% (173/212), 98.6% (209/212), and 98.6% (209/212), respectively. There was no difference between TE and WB; however, SBM was significantly different to both (p < 0.001). The informativity rate in SBM samples significantly varied among the seven centres, ranging between 72.7 and 97.1% (p = 0.041). Ploidy concordance (SBM-TE) also varied across the centres, ranging between 68.2 and 90.9%; however, this did not reach statistical significance (p = 0.63). Ploidy concordance rates in SBM-TE, SBM-WB, and TE-WB were 77.4% (130/168), 77.4% (130/168), and 90.5% (152/168), respectively. There was no statistical difference for SBM-TE and SBM-WB, but both were statistically different to TE-WB (p = 0.0054). Conclusion We have shown results that are consistent with the existing literature, indicating the feasibility of applying the niPGT-A protocol described here, and thus using the SBM result to establish a priority for embryo transfer. Trial registration information The study was approved by Tokushima University Hospital Life Science and Medical Research Ethics Review Committee (Permission number: 4057).
- Open Access
- 1 June 2025
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 07 (02) , 95-102
Pre-Vitrification Artificial Shrinkage Mitigates the Cryo-Injury When Biopsied Blastocysts are Already Re-Expanding
Introduction: Vitrifying blastocysts immediately after trophectoderm biopsy is recommended in clinical settings. However, in some cases, embryologists cannot perform vitrification immediately after biopsy because of other tasks, during which the blastocysts may begin to re-expand. Aims: This study aimed to investigate whether artificial shrinkage (AS) before vitrification affects adhesion capabilities and outgrowth competence of biopsied blastocysts with various re-expansion degrees. Methods: In total, 225 vitrified human blastocysts donated for research by consenting couples were used. Biopsied blastocysts were vitrified at 0–3 hours post-biopsy. The re-expansion degree (%) just before vitrification was calculated using the blastocyst diameter post-biopsy (Db), diameter just before vitrification (Dv), and intra-zona pellucida diameter (Dz) according to the following formula: (Dv - Db)/(Dz - Db) × 100. The blastocysts were categorized according to re-expansion degree as Expansion I, [ ] 0%; Expansion II, 1%–49%; Expansion III, 50%–99%; and Expansion IV, [ ]100%. Some blastocysts were artificially shrunk in hypertonic solution before vitrification. Correlations among outgrowth outcomes, re-expansion degree, and AS were examined. Results: Multivariate linear regression analysis demonstrated that the blastocyst outgrowth area was significantly smaller in the Expansion III group ([ ] = 0.0134). The outgrowth area in the Expansion III group was recovered by AS before vitrification ([ ] = 0.0103) and was comparable to those observed in the Expansion I, II, and IV groups. Conclusions: The outgrowth competence was adversely affected when blastocysts were vitrified during the late re-expansion period; however, this adverse effect was mitigated by pre-vitrification AS. Our findings may contribute to the improvement of day-to-day practices in embryology laboratories.
- 1 June 2025
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 07 (02) , 95-102
Open AccessPre-Vitrification Artificial Shrinkage Mitigates the Cryo-Injury When Biopsied Blastocysts are Already Re-Expanding
Introduction: Vitrifying blastocysts immediately after trophectoderm biopsy is recommended in clinical settings. However, in some cases, embryologists cannot perform vitrification immediately after biopsy because of other tasks, during which the blastocysts may begin to re-expand. Aims: This study aimed to investigate whether artificial shrinkage (AS) before vitrification affects adhesion capabilities and outgrowth competence of biopsied blastocysts with various re-expansion degrees. Methods: In total, 225 vitrified human blastocysts donated for research by consenting couples were used. Biopsied blastocysts were vitrified at 0–3 hours post-biopsy. The re-expansion degree (%) just before vitrification was calculated using the blastocyst diameter post-biopsy (Db), diameter just before vitrification (Dv), and intra-zona pellucida diameter (Dz) according to the following formula: (Dv - Db)/(Dz - Db) × 100. The blastocysts were categorized according to re-expansion degree as Expansion I, [ ] 0%; Expansion II, 1%–49%; Expansion III, 50%–99%; and Expansion IV, [ ]100%. Some blastocysts were artificially shrunk in hypertonic solution before vitrification. Correlations among outgrowth outcomes, re-expansion degree, and AS were examined. Results: Multivariate linear regression analysis demonstrated that the blastocyst outgrowth area was significantly smaller in the Expansion III group ([ ] = 0.0134). The outgrowth area in the Expansion III group was recovered by AS before vitrification ([ ] = 0.0103) and was comparable to those observed in the Expansion I, II, and IV groups. Conclusions: The outgrowth competence was adversely affected when blastocysts were vitrified during the late re-expansion period; however, this adverse effect was mitigated by pre-vitrification AS. Our findings may contribute to the improvement of day-to-day practices in embryology laboratories.
- 16 April 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (6) , 1781-1793
Diverse developmental velocities of blastocyst development emerge as early as a few hours after insemination: morphokinetic analysis of fertilisation in days 4–7 blastocysts
Purpose The time at which embryo developmental velocity variations occur remains unknown. Therefore, we analysed the morphokinetic trajectory of human early fertilisation from the extrusion of the second polar body (PB2) to pronuclear breakdown (PNBD) and retrospectively compared its alterations during the fertilisation of day 4–7 blastocysts. Methods Patients (n = 905) who underwent oocyte retrieval and blastocyst expansion between October 2019 and December 2020 were included. This study involved time-lapse technology monitoring of day 4 (n = 29), 5 (n = 1181), 6 (n = 244), and 7 (n = 12) blastocysts generated over 1009 intracytoplasmic sperm injection cycles. Morphokinetics during fertilisation were compared among the day 4–7 blastocyst groups. Results The timing of fertilisation events in the cytoplasm and pronuclei (PN) differed among the day 4–7 blastocyst groups from the outset. PB2 extrusion occurred significantly earlier in day 4 blastocysts than in day 5 blastocysts. The duration of the cytoplasmic halo was shortened in day 4 blastocysts and prolonged in day 6 blastocysts compared with that in day 5 blastocysts. Paternal PN appeared earlier in day 4 blastocysts than in day 5 blastocysts, whereas their appearance was delayed in day 6 blastocysts. In paternal and maternal PN, the time interval from PN appearance to PNBD was shortened in day 4 blastocysts but was prolonged in day 6 and 7 blastocysts. Conclusions Embryos that reached the blastocyst stage between days 4 and 7 displayed different morphokinetic speeds throughout fertilisation and as early as PB2 extrusion. Aberrant cytoplasmic granules, organelles, and PN rearrangement may contribute to these differences.
- 16 April 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (6) , 1781-1793
Diverse developmental velocities of blastocyst development emerge as early as a few hours after insemination: morphokinetic analysis of fertilisation in days 4–7 blastocysts
Purpose The time at which embryo developmental velocity variations occur remains unknown. Therefore, we analysed the morphokinetic trajectory of human early fertilisation from the extrusion of the second polar body (PB2) to pronuclear breakdown (PNBD) and retrospectively compared its alterations during the fertilisation of day 4–7 blastocysts. Methods Patients (n = 905) who underwent oocyte retrieval and blastocyst expansion between October 2019 and December 2020 were included. This study involved time-lapse technology monitoring of day 4 (n = 29), 5 (n = 1181), 6 (n = 244), and 7 (n = 12) blastocysts generated over 1009 intracytoplasmic sperm injection cycles. Morphokinetics during fertilisation were compared among the day 4–7 blastocyst groups. Results The timing of fertilisation events in the cytoplasm and pronuclei (PN) differed among the day 4–7 blastocyst groups from the outset. PB2 extrusion occurred significantly earlier in day 4 blastocysts than in day 5 blastocysts. The duration of the cytoplasmic halo was shortened in day 4 blastocysts and prolonged in day 6 blastocysts compared with that in day 5 blastocysts. Paternal PN appeared earlier in day 4 blastocysts than in day 5 blastocysts, whereas their appearance was delayed in day 6 blastocysts. In paternal and maternal PN, the time interval from PN appearance to PNBD was shortened in day 4 blastocysts but was prolonged in day 6 and 7 blastocysts. Conclusions Embryos that reached the blastocyst stage between days 4 and 7 displayed different morphokinetic speeds throughout fertilisation and as early as PB2 extrusion. Aberrant cytoplasmic granules, organelles, and PN rearrangement may contribute to these differences.
- Open Access
- 14 April 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (7) , 2514
Correction: Embryonic Outcomes, Live-Birth Outcomes After Embryo Transfer, and Euploid Rates for Various Direct Cleavage Timing Definitions During First Cytokinesis: A Single-Center, Large-Cohort, Retrospective Study
- 14 April 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (7) , 2514
Open AccessCorrection: Embryonic Outcomes, Live-Birth Outcomes After Embryo Transfer, and Euploid Rates for Various Direct Cleavage Timing Definitions During First Cytokinesis: A Single-Center, Large-Cohort, Retrospective Study
- 3 April 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (6) , 1876-1885
Embryonic Outcomes, Live-Birth Outcomes After Embryo Transfer, and Euploid Rates for Various Direct Cleavage Timing Definitions During First Cytokinesis: A Single-Center, Large-Cohort, Retrospective Study
Although essential to confirm the clinical utility of direct cleavage embryos, the timing of rapid cleavage (RpiC) has not been specifically defined. This study aimed to explore the differences in embryonic and clinical outcomes based on varying timing parameters of direct cleavage during first cytokinesis, using time to reach the three-cell stage (t3) minus time to reach the two-cell stage (t2). We analyzed 19,796 fertilized embryos (in 6,907 patients) from a single center between September 2019 and December 2020. The embryos were cultured using EmbryoScope, and t2 and t3 were recorded. Trichotomous mitosis (TM) was defined as t3 − t2 = 0 h, and RpiC events were divided into four groups, as follows: 0 h < t3 − t2 < 1 h (RpiC-1), 1 h ≤ t3 − t2 < 3 h (RpiC-3), 3 h ≤ t3 − t2 < 5 h (RpiC-5), and 5 h ≤ t3 − t2 < 7 h (RpiC-7). Additionally, 7 h ≤ t3 − t2 < 14 h was defined as normal cleavage. After single-cleavage embryo transfer, the live-birth, TM, and RpiC-1 rates were significantly lower than those in other groups. Similarly, when blastocysts were utilized, the TM and RpiC-1 rates were significantly lower than those in other groups. This study suggests that embryos with TM or RpiC-1 (t3 − t2 < 1 h) should be cultured to the blastocyst stage to prevent unnecessary embryo transfers, although outcomes may vary in different scenarios, i.e., by institution and patient.
- 3 April 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (6) , 1876-1885
Embryonic Outcomes, Live-Birth Outcomes After Embryo Transfer, and Euploid Rates for Various Direct Cleavage Timing Definitions During First Cytokinesis: A Single-Center, Large-Cohort, Retrospective Study
Although essential to confirm the clinical utility of direct cleavage embryos, the timing of rapid cleavage (RpiC) has not been specifically defined. This study aimed to explore the differences in embryonic and clinical outcomes based on varying timing parameters of direct cleavage during first cytokinesis, using time to reach the three-cell stage (t3) minus time to reach the two-cell stage (t2). We analyzed 19,796 fertilized embryos (in 6,907 patients) from a single center between September 2019 and December 2020. The embryos were cultured using EmbryoScope, and t2 and t3 were recorded. Trichotomous mitosis (TM) was defined as t3 − t2 = 0 h, and RpiC events were divided into four groups, as follows: 0 h < t3 − t2 < 1 h (RpiC-1), 1 h ≤ t3 − t2 < 3 h (RpiC-3), 3 h ≤ t3 − t2 < 5 h (RpiC-5), and 5 h ≤ t3 − t2 < 7 h (RpiC-7). Additionally, 7 h ≤ t3 − t2 < 14 h was defined as normal cleavage. After single-cleavage embryo transfer, the live-birth, TM, and RpiC-1 rates were significantly lower than those in other groups. Similarly, when blastocysts were utilized, the TM and RpiC-1 rates were significantly lower than those in other groups. This study suggests that embryos with TM or RpiC-1 (t3 − t2 < 1 h) should be cultured to the blastocyst stage to prevent unnecessary embryo transfers, although outcomes may vary in different scenarios, i.e., by institution and patient.
- 7 November 2024
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 50 (5) , 104701
Effects of unequal-sized pronuclei and their origin on embryo development and obstetric outcomes: a time-lapse retrospective study
- 7 November 2024
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 50 (5) , 104701
Effects of unequal-sized pronuclei and their origin on embryo development and obstetric outcomes: a time-lapse retrospective study
- 23 September 2024
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 50 (1) , 104454
Influence of the shortened warming protocol on human blastocyst viability: an in-vitro experimental study
- 23 September 2024
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 50 (1) , 104454
Influence of the shortened warming protocol on human blastocyst viability: an in-vitro experimental study